Bosutinib is a type of targeted therapy called a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins in the body that control how cells grow and divide. Bosutinib blocks (inhibits) signals in the leukaemia cells that make them grow and divide. Blocking the signals causes the cells to die.
It’s best to read this information with our general information about the type of cancer you have. During treatment, you will see a cancer doctor and a cancer nurse. This is who we mean when we mention doctor or nurse in this information.